Toronto Workshop on Late Recurrence in Estrogen Receptor-Positive Breast Cancer: Part 2: Approaches to Predict and Identify Late Recurrence, Research Directions

Late disease recurrence (more than 5 years after initial diagnosis) represents a clinical challenge in the treatment and management of estrogen receptor-positive breast cancer (BC). An international workshop was convened in Toronto, Canada, in February 2018 to review the current understanding of lat...

Descripción completa

Detalles Bibliográficos
Autores principales: Dowling, Ryan J O, Sparano, Joseph A, Goodwin, Pamela J, Bidard, Francois-Clement, Cescon, David W, Chandarlapaty, Sarat, Deasy, Joseph O, Dowsett, Mitch, Gray, Robert J, Henry, N Lynn, Meric-Bernstam, Funda, Perlmutter, Jane, Sledge, George W, Thorat, Mangesh A, Bratman, Scott V, Carey, Lisa A, Chang, Martin C, DeMichele, Angela, Ennis, Marguerite, Jerzak, Katarzyna J, Korde, Larissa A, Lohmann, Ana Elisa, Mamounas, Eleftherios P, Parulekar, Wendy R, Regan, Meredith M, Schramek, Daniel, Stambolic, Vuk, Whelan, Timothy J, Wolff, Antonio C, Woodgett, Jim R, Kalinsky, Kevin, Hayes, Daniel F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7050024/
https://www.ncbi.nlm.nih.gov/pubmed/32337478
http://dx.doi.org/10.1093/jncics/pkz049

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7050024/
https://www.ncbi.nlm.nih.gov/pubmed/32337478
http://dx.doi.org/10.1093/jncics/pkz049

Ejemplares similares